Description

2(1H)-Quinoxalinone,3,4-Dihydro-4-[(1,2,4-Triazolo[4,3-A]Pyrimidin-3-Ylthio)Acetyl]-(9Ci) is a sophisticated heterocyclic compound that serves as a critical advanced pharmaceutical intermediate and research chemical. Its unique molecular architecture, combining quinoxalinone and triazolopyrimidine moieties, makes it a valuable building block for the development of novel bioactive molecules. This compound is primarily sought by pharmaceutical R&D and fine chemical synthesis teams focused on creating new therapeutic agents.

Application

• Pharmaceutical Intermediate: Key precursor in the synthesis of potential drug candidates targeting various diseases.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and library synthesis in drug discovery.
• Biochemical Tool Compound: Employed in biochemical assays to study enzyme inhibition or receptor modulation, given its fused heterocyclic structure.
• Agrochemical Research: Investigated as an intermediate for developing new crop protection agents with novel modes of action.
• Organic Synthesis Building Block: Utilized in academic and industrial labs for constructing complex polyheterocyclic systems.
• Chemical Biology Probes: Potential candidate for developing labeled probes to study biological pathways.

Basic Information

Product Name	2(1H)-Quinoxalinone,3,4-Dihydro-4-[(1,2,4-Triazolo[4,3-A]Pyrimidin-3-Ylthio)Acetyl]-(9Ci)
CAS No.	606121-80-6
Molecular Formula	C15H11N7O2S
Molecular Weight	353.36 g/mol
Synonyms	4-[(1,2,4-Triazolo[4,3-a]pyrimidin-3-ylsulfanyl)acetyl]-3,4-dihydro-1H-quinoxalin-2-one; 3,4-Dihydro-4-[(1,2,4-triazolo[4,3-a]pyrimidin-3-ylthio)acetyl]-2(1H)-quinoxalinone; 4-[(1,2,4-Triazolo[4,3-a]pyrimidin-3-ylthio)acetyl]-3,4-dihydroquinoxalin-2(1H)-one; 606121-80-6; SCHEMBL2183307; AKOS040750623; ZINC000003920726; A-934
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management systems. Each batch undergoes comprehensive analytical characterization using techniques such as HPLC, NMR, and MS to ensure identity, purity, and batch-to-batch consistency. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting all critical quality attributes. We support cGMP-compliant manufacturing for pharmaceutical applications upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). The compound may be moisture-sensitive; keep the container tightly sealed under an inert atmosphere if necessary. Keep away from heat and incompatible materials.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (HPLC)	Conforms
Identification (IR)	Conforms to reference spectrum
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.